Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: Two decades of experience at Chang Gung Memorial Hospital

Table 3 Laboratory data of 1224 HCC patients undergoing hepatectomy with and without ESRD.

	ESRD–HCC (%) (n = 26)	HCC (%) (n = 1198)	P
AFP (ng/mL)	2143.7±10365.5	6520.9±99070.2	0.825
AFP>400 ng/mL	2/25 (8.0)	392/1098 (35.7)	0.003
Hemoglobin (g/dL)	10.6±2.5	13.0±2.1	0.0001
WBC (/µL)	6284.6±3031.0 7	467.6±7956.4	0.449
Platelet (103/µL)	134.7±77.0	179.4±99.2	0.023
PT/PT (normal control)	0.85±1.6	0.96±1.9	0.778
INR (%)	1.10±0.16	1.10±0.18	0.953
Albumin (g/dL)	3.70±0.67	3.90±0.62	0.115
Bilirubin (direct) (mg/dL)	0.30±0.14	0.51±1.16	0.588
Bilirubin (total) (mg/dL)	0.80±0.36	1.12±1.27	0.207
BUN (mg/dL)	54.9±26.9	15.5±7.1	0.0001
Creatinine (mg/dL)	6.64±4.01	1.21±1.69	0.0001
AST (IU/L)	63.5±55.5	72.6±96.0	0.631
ALT (IU/L)	46.6±51.1	63.9±71.0	0.236
ALP (IU/L)	101.5±45.2	114.7±295.6	0.827
ICG 15 (%)	19.4±15.6	14.5±13.9	0.143

AFP: α-fetoprotein; PT: prothrombin time; INR: international normalized ratio; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; ICG 15: indocyanine green retention rate at 15 min.